Global Molecular Point of Care Diagnostics Market (2019 to 2028) - Featuring Abbott, Abacus Diagnostica & Biomerieux Among Others - ResearchAndMarkets.com

DUBLIN--()--The "Global Molecular Point of Care Diagnostics Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.

According to this report the global molecular point of care diagnostics market is estimated to grow with a CAGR of 14.05% in the projected period 2019-2028.

The escalating demand for diagnostic technology due to the widespread of COVID-19 is a basic factor driving the growth of the global molecular point of care diagnostics market. In addition, the growing demand for non-invasive diagnosis and their further development, along with the increasing prevalence of diseases throughout the world, is also driving the global market growth. Key opportunities like the overall increase in the spending on R&D activities and the successful innovations in the market must be leveraged to reach the projected growth. However, the high capital requirement is hampering the market growth. Also, insufficient high complexity test centers are a challenge to global market growth.

The global market report covers the countries from North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa.

Asia-Pacific is likely to be the fastest-growing region for the molecular point of care diagnostics market. The growing demand for molecular point of care diagnosis by both patients and physicians in countries like Japan is likely to lead to market growth. Moreover, governments in this region are taking several initiatives to promote the adoption of precision medicine solutions, thereby aiding the regional market growth.

Companies Mentioned

  • Abbott
  • Abacus Diagnostica
  • Biomerieux SA
  • Biocartis
  • Danaher
  • Diasorin SPA
  • Bio-Rad Laboratories Inc
  • F Hoffmann-La Roche Ltd
  • Luminex Corporation
  • Hologic Inc
  • Mesa Biotech
  • Spartan Biosciences Inc
  • Quantumdx Group Ltd
  • Quidel Corporation
  • Qiagen

Market Dynamics

Drivers

  • Demand for Diagnosing Presence of Sars Cov-2
  • Increasing Demand for Non-Invasive Diagnosis
  • Rise in the Number of Diseases

Restraints

  • High Capital Requirement

Opportunities

  • Spending on Research & Development
  • Innovations in the Market

Challenges

  • Lack of High Complexity Testing Centers

     

For more information about this report visit https://www.researchandmarkets.com/r/k5x6ea

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900